RetiSpec

Toronto, Canada

RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer's Disease pathology.

$10.0M raised

Jul 2024

Series A

Top Investors

Eli LillyiGan PartnersMassChallengeUniversity of MinnesotaCenter of Aging and Brain Health Innovation

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has RetiSpec raised?

RetiSpec has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in July 2024.

Who are RetiSpec's investors?

RetiSpec's investors include Eli Lilly, iGan Partners, MassChallenge, University of Minnesota, Center of Aging and Brain Health Innovation.

Where is RetiSpec headquartered?

RetiSpec is headquartered in Toronto, Canada.

What does RetiSpec do?

RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer's Disease pathology.

What stage is RetiSpec at?

RetiSpec is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 26, 2024.

MLA

"RetiSpec — Funding & Investors." VCBacked, July 26, 2024, https://www.vcbacked.co/company/retispec. Accessed June 4, 2026.

APA

VCBacked. (2024). RetiSpec — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/retispec

Wikipedia (cite web)

{{cite web |title=RetiSpec — Funding & Investors |url=https://www.vcbacked.co/company/retispec |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 26, 2024.